• What’s important and/or interesting in health care?

    Every so often someone asks me one of the questions I hate: “What is the most important and under-discussed health policy issue right now?” or some variant thereof.

    I hate it because of how I’m wired, not because it’s a bad question. The truth is, just about every health policy issue of import right now is a variant of an issue that has been important for decades and isn’t going away anytime soon either, whether under-discussed or not. My brain just isn’t as tuned to what’s hot and under-discussed as to what’s interesting (to me) or important (for one reason or another) all the time.

    This got me thinking, just what is it that I find interesting and important all the time? These would naturally be the issues that attract me to whatever papers I pull from the dozens of journal tables of contents I receive each week. Some papers are must reads (to me). Others I pass up.These are also issues I’m very likely to write about again and again.

    In no particular order, here’s the list I’ve been making on subject areas I almost always care about, with some notes on whether I think each is broadly important for policy or mostly just interesting to me (because I’m weird):

    • Medicaid access—important
    • Narrow networks—important
    • ACO performance—important
    • Effects of payments level and manner on health care quality and outcomes—important and basically a generalization of interest ACOs
    • Wellness programs, specifically how they affect health and spending—important. Many companies really are interested in or implementing these. They ought to really care what the impacts are.
    • Consolidation in the health care market (horizontal and vertical) and implications—important
    • Medicare advantage market, growth, value, costs, including premium support-like reforms—important
    • Part D market—important
    • Consumer decision-making in health insurance markets—interesting. I just don’t see results of work in this area binding on policy, but I could be wrong.
    • Cost shifting—interesting
    • Reference pricing—important
    • The opioid epidemic—important
    • Hospital or health sector productivity—interesting
    • Comparative effectiveness, cost effectiveness, and the management of health care technology—important
    • Observational methods for causal inference/big data—interesting
    • Labor market and health care (job lock, premium-wage trade-off)—interesting
    • Consumer directed health plans—important
    • Quality measurement and incentives—important
    • Management of and leadership in health care—interesting
    • Data access for research—important
    • Placebo effects—interesting
    • Any clinical area with which I have personal experience as a patient (insomnia, kidney stones, etc.)—interesting
    • Scientific communication—important

    I probably forgot some things I’m actually interested, and have revealed as much in my posts. If you think so, remind me! Also, maybe you think I should find something not on this list to be important or interesting enough to pay close attention to. If so, what is it? Tell me on Twitter or by email.


    Comments closed